151 related articles for article (PubMed ID: 22127362)
81. [Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer].
Touboul C; Uzan C; Mauguen A; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Haie-Meder C; Morice P
J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8):624-31. PubMed ID: 21030163
[TBL] [Abstract][Full Text] [Related]
82. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
[TBL] [Abstract][Full Text] [Related]
83. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
84. Srinagarind Hospital experience in concurrent chemoradiation for 100 patients with stage IB2 to IVA uterine cervical cancer.
Tangsiriwatthana T; Chumworathayi B; Yuenyao P; Luanratanakorn S; Pattamadilok J
Radiat Med; 2007 Dec; 25(10):502-10. PubMed ID: 18085400
[TBL] [Abstract][Full Text] [Related]
85. [Radiotherapy concomitant with cisplatin chemotherapy in the treatment of cancer of the cervix uteri].
Bild E; Buiuc A; Albulescu E
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):99-102. PubMed ID: 9524663
[TBL] [Abstract][Full Text] [Related]
86. Management of recurrent cervical cancer: a review of the literature.
Peiretti M; Zapardiel I; Zanagnolo V; Landoni F; Morrow CP; Maggioni A
Surg Oncol; 2012 Jun; 21(2):e59-66. PubMed ID: 22244884
[TBL] [Abstract][Full Text] [Related]
87. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
Kim HS; Kim JY; Park NH; Kim K; Chung HH; Kim YB; Kim JW; Kim HJ; Song YS; Kang SB
Gynecol Oncol; 2010 Nov; 119(2):217-24. PubMed ID: 20705335
[TBL] [Abstract][Full Text] [Related]
88. A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
Pu J; Qin SS; Ding JX; Zhang Y; Zhu WG; Yu CH; Li T; Tao GZ; Ji FZ; Zhou XL; Han JH; Ji YL; Sun JX
J Cancer Res Clin Oncol; 2013 Apr; 139(4):703-8. PubMed ID: 23328996
[TBL] [Abstract][Full Text] [Related]
89. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Varia MA; Bundy BN; Deppe G; Mannel R; Averette HE; Rose PG; Connelly P
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1015-23. PubMed ID: 9869224
[TBL] [Abstract][Full Text] [Related]
90. A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix.
Koumantakis E; Haralambakis Z; Koukourakis M; Mazonakis M; Haldeopoulos D; Papageorgiou N; Livas V; Froudarakis G; Varveris H
Br J Radiol; 1998 May; 71(845):552-7. PubMed ID: 9691902
[TBL] [Abstract][Full Text] [Related]
91. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.
Stehman FB; Ali S; Keys HM; Muderspach LI; Chafe WE; Gallup DG; Walker JL; Gersell D
Am J Obstet Gynecol; 2007 Nov; 197(5):503.e1-6. PubMed ID: 17980189
[TBL] [Abstract][Full Text] [Related]
92. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
93. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
94. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
[TBL] [Abstract][Full Text] [Related]
95. Treatment of FIGO stage Ib cervical carcinoma with nodal involvement.
Pedullà F; Centurioni MG; Foglia G; Ferrari I; Orsatti M; Vitale V; Ragni N
Eur J Gynaecol Oncol; 1994; 15(1):59-64. PubMed ID: 8206073
[TBL] [Abstract][Full Text] [Related]
96. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
97. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer.
Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N
Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856
[TBL] [Abstract][Full Text] [Related]
98. Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcome.
Vandecasteele K; Makar A; Van den Broecke R; Delrue L; Denys H; Lambein K; Lambert B; van Eijkeren M; Tummers P; De Meerleer G
Strahlenther Onkol; 2012 Jul; 188(7):576-81. PubMed ID: 22526231
[TBL] [Abstract][Full Text] [Related]
99. Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Lopez-Graniel C; Dolores R; Cetina L; Gonzalez A; Cantu D; Chanona J; Uribe J; Candelaria M; Brom R; de la Garza J; Duenas-Gonzalez A
BMC Cancer; 2005 Sep; 5():118. PubMed ID: 16171526
[TBL] [Abstract][Full Text] [Related]
100. Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.
Agoni L; Basu I; Gupta S; Alfieri A; Gambino A; Goldberg GL; Reddy EP; Guha C
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1180-7. PubMed ID: 24529717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
